Clinical Trials in Salt Lake City

Showing 1981-2000 of 7,997 trials

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

NCT04648202

This is a Phase 1/1b, multicenter, open label study to evaluate the Safety and Antitumor Activity of FS120, an OX40/CD137 Bispecific Antibody, Alone and in Combination with Pembrolizumab, in Subjects with Advanced Malignancies

Advanced CancerMetastatic Cancer

invoX Pharma Limited82 participantsStarted Nov 2020

New Haven, Connecticut, United States • Houston, Texas, United States • San Antonio, Texas, United States +6 more locations

COMPLETEDNA< 1 mile

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

NCT06534424

This clinical trial evaluates the impact of enhanced risk assessments on knowledge, perceptions, and decisional conflict about cancer prevention in women with a BRCA1 or BRCA2 mutation. BRCA1/2 mutation carriers have a much higher risk of developing breast and ovarian cancer. Due to the high risk of cancer, mutation carriers are provided guidelines on more intensive screening and preventative surgeries such as bilateral mastectomy and bilateral salpingo-oophorectomy. Doctors want to learn if a more personalized risk assessment impacts the patients' risk perceptions and comfort with decision-making around cancer prevention behaviors.

BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome

Ohio State University Comprehensive Cancer Center152 participantsStarted Jan 2018

Columbus, Ohio, United States • Salt Lake City, Utah, United States

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Find Trials by Condition in Salt Lake City

Macular Pigment Measurements in Eye & Other Tissues

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

NasoShield in Healthy Adults to Study Safety and Immunogenicity

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

Relationship Between Alterations in the GI Microbiome and GI Inflammation on Symptom Burden in Women With Breast Cancer Receiving Chemotherapy

A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b

Clinical Investigation of the Next-Generation Intraocular Lens

Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas

A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients

A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.

The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)

Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain

Cough Reduction in IPF With Nalbuphine ER